Molidustat Targets a Synthetic Lethal Vulnerability in APC-Mutant Colorectal Cancer through GSTP1 and PHD2 Co-Inhibition
Chiara Asselborn, Agata N Makar, Jair G Marques…·Alex von Kriegsheim
This study identifies Molidustat's anti-tumor effect in APC-mutant colorectal cancer through co-inhibition of GSTP1 and PHD2, revealing a synthetic lethal interaction.